InsidersTradesSigma
Declaraciones totales
Empresa
▲ Compras (0 oper.)
▼ Ventas (9 oper.)
Historial del iniciado
DirectivoCompras declaradas
0
Ventas declaradas
9
Tasa de acierto T+90
0%
Rendimiento medio T+90
-6.8%
Sobre 2 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Discover the complete record of transactions filed by Skynner Michael, Director de Tecnología. Insider active across 1 company, notably BICYCLE THERAPEUTICS plc. Aggregated, 14 filings have been logged. Breakdown: 0 buy · 9 sells. Total volume traded: €101k. Activity tracked since 3 January 2022. The latest transaction was disclosed on 2 July 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declaraciones14 en total
1859 títulos@ 4,27 US$0.0027% mcap6.9% de su flujoOrdinary SharesSEC:0001776582-26-000006:0
532 títulos@ 4,31 US$0.0008% mcap2.0% de su flujoOrdinary SharesSEC:0001776582-26-000006:1
814 títulos@ 8,02 US$6.5% de su flujoOrdinary SharesSEC:0001415889-25-010244:0
35.000 títulos0Ordinary SharesSEC:0001415889-25-000923:0
972 títulos@ 22,26 US$21.4% de su flujoOrdinary SharesSEC:0001415889-24-024770:0
967 títulos@ 19,64 US$19.2% de su flujoOrdinary SharesSEC:0001415889-24-019388:0
955 títulos@ 23,81 US$22.9% de su flujoOrdinary SharesSEC:0001415889-24-010417:0
28.000 títulos0Ordinary SharesSEC:0001209191-24-000876:0
442 títulos@ 20,00 US$9.2% de su flujoOrdinary SharesSEC:0001209191-23-052248:0
451 títulos@ 25,10 US$11.3% de su flujoOrdinary SharesSEC:0001209191-23-041574:0
447 títulos@ 21,11 US$9.4% de su flujoOrdinary SharesSEC:0001209191-23-023350:0
17.500 títulos0Ordinary SharesSEC:0001209191-23-002198:0
15.000 títulos0Ordinary SharesSEC:0001209191-22-001823
15.000 títulos0Ordinary SharesSEC:0001209191-22-001823:0
14 de 14 declaraciones
About Skynner Michael
Michael Skynner serves as the Chief Technology Officer at Bicycle Therapeutics plc. In this role, he is responsible for the company's technological direction, ensuring that innovations support strategic objectives. His expertise in biotechnology and ability to lead technical teams are essential for the development of new products. He plays a key role in the continuous improvement of the company's systems and processes.
